
Turning wild-type phages into drug-grade ε²Phages®
What makes PhagoMed’s ε²Phages® special?
PhagoMed creates novel phage genotypes through directed inter-crossings of wild-type phages on our ε² Directed Evolution platform. The resulting ε²Phages® are highly evolved and optimized for therapeutic applications:
-
Optimized for high host range & low resistance formation
-
Only natural inter-crossing techniques used to create ε²Phages®
-
Bio-availability optimized for the exact treatment setting
-
Broad patent protection secured
Natural phages recombined to create phages with superior phenotype
Natural phage 3
Natural phage 4
ε²Phage®
Recombinations
